DISCOUNT-OPTIONSSCHEIN - AMGEN | Real-time BOERSE MUENCHEN 14:45:27 23/05/2024 BST | ||
| 1.24 EUR | -5.34% |
|
| Current month | +77.03% | ||
| 1 month | +84.51% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
AMGEN INC.
Latest news about AMGEN INC.
| Date | Price | Change |
|---|---|---|
| 23/05/24 | 1.24 | -5.34% |
| 22/05/24 | 1.31 | -2.24% |
| 21/05/24 | 1.34 | +2.29% |
| 20/05/24 | 1.31 | +0.77% |
| 17/05/24 | 1.3 | -1.52% |
Real-time BOERSE MUENCHEN
Last update May 23, 2024 at 02:45 pm
More quotesStatic data
| Product type | Produits Exotiques |
|---|---|
| Buy / Sell | CALL |
| Underlying | AMGEN INC. |
| Issuer | 
UniCredit
|
| WKN | HC8K4F |
| ISIN | DE000HC8K4F6 |
| Date issued | 10/08/2023 |
| Strike | 300 $ |
| Maturity | 18/12/2024 (209 Days) |
| Parity | 10 : 1 |
| Emission price | 0.74 € |
| Emission volume | N/A |
| Settlement | règlement en espèces |
| Currency | EUR |
Technical Indicators
| Highest since issue | 1.47 € |
|---|---|
| Lowest since issue | 0.58 € |
| Spread | 0.04 € |
| Spread % | 3.31% |
Company Profile
Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows:
- drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.;
- other (5.8%): primarily royalties.
The United States account for 70.3% of net sales.
Sector
-
Consensus: Amgen Inc.
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
30
Last Close Price
309.4
USD
Average target price
316.1
USD
Spread / Average Target
+2.15%
- Stock Market
- Certificates
- Certificat
